UniPharma Co., Ltd. (TPEX:6621)
Taiwan
· Delayed Price · Currency is TWD 12.85
-0.20 (-1.53%)
Apr 29, 2026, 1:45 PM CST
UniPharma Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -40.54 | -24.82 | -21.81 | -6.45 | -74.41 | Upgrade
|
| Depreciation & Amortization | 6.89 | 6.98 | 5.53 | 5.48 | 10.72 | Upgrade
|
| Other Amortization | 0.11 | 0.02 | 0.02 | 0.05 | 0.06 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.04 | - | -10.71 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 36.43 | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.46 | - | Upgrade
|
| Other Operating Activities | -0.04 | - | - | -0.58 | -0.01 | Upgrade
|
| Change in Accounts Receivable | 1.64 | 4.1 | 10.24 | -9.91 | 2.41 | Upgrade
|
| Change in Inventory | -9.03 | 6.67 | 2.1 | 4.89 | -10.28 | Upgrade
|
| Change in Accounts Payable | 3.55 | -7.77 | 16.15 | -21.56 | 25.44 | Upgrade
|
| Change in Unearned Revenue | -0.06 | -0.15 | -0.4 | 0.71 | -0.14 | Upgrade
|
| Change in Other Net Operating Assets | 0.79 | 0.61 | 0.2 | 5.96 | -3.15 | Upgrade
|
| Operating Cash Flow | -36.67 | -14.32 | 12.03 | -31.65 | -12.93 | Upgrade
|
| Capital Expenditures | -1.31 | -0.79 | -8.11 | -0.44 | -0.61 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.05 | - | Upgrade
|
| Divestitures | - | - | - | 3.32 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.57 | -2.05 | - | - | -2.6 | Upgrade
|
| Investment in Securities | 12.35 | 9.24 | 3.53 | -6 | 25.55 | Upgrade
|
| Other Investing Activities | 0.2 | 1.78 | 0.69 | 1.95 | -2.55 | Upgrade
|
| Investing Cash Flow | 10.67 | 8.18 | -3.89 | -1.12 | 19.8 | Upgrade
|
| Long-Term Debt Repaid | -3.68 | -3.55 | -3.26 | -3.43 | -5.49 | Upgrade
|
| Net Debt Issued (Repaid) | -3.68 | -3.55 | -3.26 | -3.43 | -5.49 | Upgrade
|
| Issuance of Common Stock | - | - | - | 3 | - | Upgrade
|
| Other Financing Activities | - | -0.29 | - | 21 | - | Upgrade
|
| Financing Cash Flow | -3.68 | -3.83 | -3.26 | 20.57 | -5.49 | Upgrade
|
| Net Cash Flow | -29.68 | -9.97 | 4.89 | -12.2 | 1.37 | Upgrade
|
| Free Cash Flow | -37.98 | -15.11 | 3.92 | -32.09 | -13.54 | Upgrade
|
| Free Cash Flow Margin | -42.94% | -16.17% | 3.80% | -25.05% | -12.85% | Upgrade
|
| Free Cash Flow Per Share | -1.07 | -0.43 | 0.11 | -0.90 | -0.39 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.1 | 0.01 | 0.04 | 0.1 | Upgrade
|
| Cash Income Tax Paid | 0.04 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | -24.01 | -6.33 | 8.63 | -15.42 | -26.34 | Upgrade
|
| Unlevered Free Cash Flow | -23.95 | -6.26 | 8.64 | -15.4 | -26.28 | Upgrade
|
| Change in Working Capital | -3.1 | 3.46 | 28.3 | -19.91 | 14.27 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.